Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III maintenance study of AJG501 in patients with ulcerative colitis
jRCT2080221044Phase 3
- Sponsor
- Ajinomoto
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing AJG501 with Placebo (2 arms).
02
Drugs
carotegrast methyl
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080221044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221044.